Clinical Trial Update: Evaluation of Clonazepam and Paroxetine for Panic Disorder With Depression [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update reporting completion of a study evaluating clonazepam and paroxetine for panic disorder with depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Panic Disorder

Drugs mentioned

• KLONOPIN (clonazepam)
• PAXIL (paroxetine hydrochloride)

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Panic Disorder | Phase 4 | Status: COMPLETED